- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lung Diseases, Obstructive in United Kingdom
Total 147373 results
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Pulmatrix Inc.Quotient ClinicalCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Imperial College LondonCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
GlaxoSmithKlineTerminatedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
Imperial College LondonBoehringer IngelheimCompleted
-
Xention LtdArio Pharma LtdCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Royal Free and University College Medical SchoolBoehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Imperial College LondonAsthma UKWithdrawnHealthy Volunteers | Chronic Obstructive Airway DiseaseUnited Kingdom
-
Sunovion Respiratory Development Inc.Completed
-
Imperial College LondonCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
NHS Greater Glasgow and ClydeWithdrawnChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | Lung DiseaseUnited Kingdom
-
Chelsea and Westminster NHS Foundation TrustCompleted
-
University of SouthamptonNational Institute for Health Research, United Kingdom; Collaboration for Leadership...CompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of GlasgowUnknownChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaParexel; Covance; The Doctors Laboratory; Industrias Farmacéuticas Almirall S.A.CompletedChronic Obstructive Pulmonary Disease - COPDUnited Kingdom
-
AstraZenecaSimbec ResearchCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Prosonix LimitedCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Research in Real-Life LtdTeva Branded Pharmaceutical Products R&D, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Medicines Evaluation Unit LtdChiesi UKCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Hywel Dda Health BoardCompletedChronic Obstructive Airway Disease | Neutrophil Function DisorderUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
University of East AngliaUnknownChronic Obstructive Pulmonary Disease | Pulmonary RehabilitationUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Imperial College LondonAstraZenecaWithdrawnChronic Obstructive Pulmonary Disease (COPD) | Age Matched Healthy Volunteers (Non-smokers)United Kingdom
-
Imperial College LondonGlaxoSmithKlineTerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Respivert LtdCompletedHealthy Volunteers | Chronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Imperial College LondonCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Respivert LtdCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | AsthmaUnited Kingdom
-
Imperial College LondonWithdrawn
-
University of LincolnNational Health Service, United KingdomCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.TerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Northumbria UniversityNorth Tyneside General HospitalCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Institute of Medicinal Molecular Design, Inc.UnknownChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Liverpool Heart and Chest Hospital NHS Foundation...Edge Hill UniversityCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Liverpool Heart and Chest Hospital NHS Foundation...Edge Hill UniversityCompletedCardiovascular Diseases | Chronic Obstructive Pulmonary Disease | Pulmonary DiseaseUnited Kingdom
-
Imperial College LondonAstraZenecaWithdrawnCOPD Patients | Current Smokers | Healthy Non-smokersUnited Kingdom
-
AstraZenecaParexelCompletedSafety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedA Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001 (CHF6001Ext)Chronic Obstructive Pulmonary DiseaseUnited Kingdom
-
PfizerCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | Lung Disease Causing Persistent Narrowing of the AirwaysUnited Kingdom
-
Newcastle-upon-Tyne Hospitals NHS TrustAstraZeneca; Newcastle UniversityCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Imperial College LondonGene LogicCompletedEmphysema | COPDUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; National Institute for Health Research: CLAHRC YH; The... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Loughborough UniversityCompleted
-
Royal Brompton & Harefield NHS Foundation TrustUnknown
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease (COPD) | COPDUnited Kingdom
-
Dr Ian B WilkinsonUniversity College London Hospitals; Imperial College London; Newcastle University and other collaboratorsRecruitingChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustUnknownChronic Obstructive Pulmonary DiseaseUnited Kingdom